Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 158

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 158
---
of a separation agreement containing a release of claims in favor of Enfusion, each covered executive is eligible to receive:

| • |     | a lump sum amount equal to one year of the covered executive’s base salary as in effect immediately prior to                                                                                                                                 
 their qualified termination of employment (or, if the covered executive experienced a reduction in base salary that would give rise to a “good reason” termination, then the base salary in effect immediately prior to such reduction); and |

| • |     | if the covered executive elects continued health coverage under the Consolidated Omnibus Reconciliation Act of                                                                                                                             
 1985 as amended (“COBRA”), a monthly cash payment in an amount equal to the monthly employer contribution that Enfusion would have made to provide health insurance to the covered executive had he or she remained employed by Enfusion   
 until the earliest of (i) 12 months following termination of employment (ii) the date that the covered executive becomes eligible for group medical plan benefits with another employer, or (iii) the end of the covered executive’s COBRA 
 health continuation period.                                                                                                                                                                                                                |

Mr. Pawar Employment Agreement Pursuant to Mr. Pawar’s employment agreement with Enfusion OpCo, dated November 7, 2023, if Mr. Pawar’s employment is terminated by Enfusion OpCo without “cause” or Mr. Pawar resigns with “good reason” (as each term is defined in his employment agreement), Mr. Pawar will be offered the opportunity to enter into a separate severance agreement describing post-termination rights and obligations. The severance agreement will, at minimum, provide for severance pay in the form of cash payment equivalent to one-yearbase salary plus one-yeartarget discretionary bonus and payment of the full COBRA premiums applicable to Mr. Pawar and his eligible dependents for a period of 12 months immediately following his loss of coverage from Enfusion OpCo. When calculating one-yearbase salary and one-yeartarget bonus, Enfusion OpCo will utilize the average of both Mr. Pawar’s base salary and his discretionary bonus across the three years preceding the termination event. If Mr. Pawar is terminated prior to three full years of service, Enfusion OpCo will utilize Mr. Pawar’s entire period of employment to determine the average. Indemnification; Directors’ and Officer’s Insurance The Merger Agreement provides that directors and officers of Enfusion will have the right to indemnification and continued coverage under directors’ and officers